A Hyaluronic Acid−Taxol Antitumor Bioconjugate Targeted to Cancer Cells
Top Cited Papers
- 25 March 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 1 (2), 208-218
- https://doi.org/10.1021/bm000283n
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Fluorescence-labeled-hyaluronan loading test as an index of hepatic sinusoidal endothelial cell function in the ratInternational Hepatology Communications, 1996
- Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activityJournal of Drug Targeting, 1996
- Cell-Based Screen for Identification of Inhibitors of Tubulin PolymerizationJournal of Natural Products, 1996
- Carbohydrate-Protein Interactions in Vascular BiologyAnnual Review of Cell and Developmental Biology, 1995
- Hyaluronidases - a group of neglected enzymesProtein Science, 1995
- Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.The Journal of Experimental Medicine, 1995
- Role of CD44 cytoplasmic domain in hyaluronan bindingEuropean Journal of Immunology, 1995
- Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potentialJournal of Cellular Physiology, 1994
- Antibody‐induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibodyEuropean Journal of Immunology, 1993
- The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.The Journal of cell biology, 1992